Fisher & Paykel Healthcare Corporation Limited FSPKF
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 359.31M | 349.88M | 322.57M | 322.86M | 303.63M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 359.31M | 349.88M | 322.57M | 322.86M | 303.63M |
| Cost of Revenue | 128.27M | 124.91M | 119.37M | 119.47M | 110.01M |
| Gross Profit | 231.04M | 224.97M | 203.20M | 203.38M | 193.62M |
| SG&A Expenses | 92.10M | 89.69M | 84.61M | 84.68M | 77.74M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 256.13M | 249.41M | 237.78M | 238.00M | 220.90M |
| Operating Income | 103.18M | 100.47M | 84.78M | 84.86M | 82.73M |
| Income Before Tax | 102.41M | 99.72M | 84.10M | 84.18M | 84.27M |
| Income Tax Expenses | 27.16M | 26.44M | 20.98M | 21.00M | 20.69M |
| Earnings from Continuing Operations | 75.26M | 73.28M | 63.12M | 63.18M | 63.58M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 75.26M | 73.28M | 63.12M | 63.18M | 63.58M |
| EBIT | 103.18M | 100.47M | 84.78M | 84.86M | 82.73M |
| EBITDA | 120.62M | 117.45M | 103.69M | 103.78M | 98.43M |
| EPS Basic | 0.13 | 0.12 | 0.11 | 0.11 | 0.11 |
| Normalized Basic EPS | 0.11 | 0.11 | 0.09 | 0.09 | 0.09 |
| EPS Diluted | 0.13 | 0.12 | 0.11 | 0.11 | 0.11 |
| Normalized Diluted EPS | 0.11 | 0.11 | 0.09 | 0.09 | 0.09 |
| Average Basic Shares Outstanding | 587.27M | 587.27M | 586.59M | 586.59M | 586.13M |
| Average Diluted Shares Outstanding | 590.76M | 590.76M | 591.23M | 591.23M | 591.01M |
| Dividend Per Share | 0.10 | 0.09 | 0.06 | 0.06 | 0.07 |
| Payout Ratio | 42.28% | 42.28% | 54.40% | 54.40% | 42.92% |